FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * ZEN Wei Peu 2. Date of Event Requiring Statement (MM/DD/YYYY)
7/17/2019 

3. Issuer Name and Ticker or Trading Symbol Emmaus Life Sciences, Inc. [EMMA]
(Last)       (First)       (Middle)
21250 HAWTHORNE BLVD., SUITE 800
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)
TORRANCE, CA 90503      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
7/30/2019 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common stock, $0.001 par value  1007834 (1) D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  This Form 3/A is being filed to correct the number of shares of common stock beneficially owned directly by the Reporting Person, which was incorrectly reported as 1,007,833 on a Form 3/A filed on October 8, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ZEN Wei Peu
21250 HAWTHORNE BLVD., SUITE 800
TORRANCE, CA 90503
X



Signatures
Wei Peu Zen 12/2/2019
**Signature of Reporting Person Date
Emmaus Life Sciences (NASDAQ:EMMA)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Emmaus Life Sciences Charts.
Emmaus Life Sciences (NASDAQ:EMMA)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Emmaus Life Sciences Charts.